Item 7.01. Regulation FD Disclosure.
On January 09, 2023, Cara Therapeutics, Inc. (the "Company") made available an
updated corporate presentation that the Company will use to present at the
41stAnnual J.P. Morgan Healthcare Conference on January 9, 2023, which can be
found on the Company's website (the "Corporate Presentation"). The Corporate
Presentation is furnished as Exhibit 99.1 and incorporated by reference in this
Item 7.01.
The information furnished under this Item 7.01, including Exhibit 99.1, shall
not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act
of 1934 (the "Exchange Act") or subject to the liabilities of that section, nor
shall it be deemed to be incorporated by reference into any of the Company's
filings with the Securities and Exchange Commission ("SEC") under the Exchange
Act or the Securities Act of 1933, as amended, whether made before or after the
date hereof, regardless of any general incorporation language in such a filing.
The information shall not be deemed incorporated by reference into any other
filing with the SEC made by the Company, regardless of any general incorporation
language in such filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
Exhibit
No. Description
99.1 Corporate Presentation, dated January 9, 2023
104 Cover page interactive data file (formatted as Inline XBRL)
© Edgar Online, source Glimpses